Stocktoria
RIGEL PHARMACEUTICALS INC RIGL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2000-11-29
RIGEL PHARMACEUTICALS INC insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Ali-Jackson Kamil | director | 2026-06-22 | Sell | 2,500 | $35.00 |
| Schorno Dean L | EVP & Chief Financial Officer | 2026-06-01 | Option exercise | 1,200 | $18.70 |
| Schorno Dean L | EVP & Chief Financial Officer | 2026-06-01 | Option exercise | 2,181 | $12.70 |
| Schorno Dean L | EVP & Chief Financial Officer | 2026-06-01 | Tax withheld | 928 | $29.86 |
| Santos David A | EVP, Chief Commercial Officer | 2026-06-01 | Tax withheld | 874 | $29.86 |
| Rojkjaer Lisa | EVP, Chief Medical Officer | 2026-06-01 | Tax withheld | 850 | $29.86 |
| RODRIGUEZ RAUL R | CEO, President | 2026-06-01 | Tax withheld | 2,424 | $29.86 |
Source: SEC EDGAR filings · CIK 0001034842 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.